CBMG - Cellular Biomedicine Inc News Story
$18.11 0.2 1.3%
Last Trade - 15/01/21
| Market Cap | £259.6m |
| Enterprise Value | £275.7m |
| Revenue | £238k |
| Position in Universe | 3633rd / 6547 |
BRIEF-Cellular Biomedicine Reports Q1 Loss Per Share Of $0.60
Wed 6th May, 2020 10:51pm
May 6 (Reuters) - Cellular Biomedicine Group Inc CBMG.O :
* CELLULAR BIOMEDICINE GROUP REPORTS Q1 2020 FINANCIAL
RESULTS AND
BUSINESS HIGHLIGHTS
* CELLULAR BIOMEDICINE GROUP INC - QTRLY LOSS PER SHARE
$0.60
Source text for Eikon: ID:nPnbRsFfha
Further company coverage: CBMG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cellular Biomedicine Inc
See all news
